Our website uses cookies to distinguish you from other users of our website to provide you with the most relevant experience by remembering your preferences and repeat visits. By clicking on ‘Accept’ you consent to our cookie policy. However, you may visit ‘Cookie Settings’ to provide a controlled consent.

Accept

News

Archive

Ventyx Biosciences announces initiation of dosing in a Phase 2a trial of VTX3232 in patients with early Parkinson’s disease Vascular Therapies completes enrollment in the ACCESS 2 study, a Phase III multinational randomized clinical trial of the Sirolimus Eluting Collagen Implant (Sirogen™) for the surgical creation of arteriovenous fistula for hemodialysis vascular access Ventyx Biosciences announces results from the Phase 2 trial of VTX958 in participants with moderately to severely active Crohn’s disease Emporos and InterLink AI Partner, develop only POS-Integrated lighted will-call solution Phase Four partners with Redwire to expand space propulsion offerings and deliver Hall Effect Thrusters Primemas selects Achronix embedded FPGA technology for System-on-Chip (SoC) Hub Chiplet platform
Back To News
Sensor Platforms
October 17, 2017

Sensor Platforms

Acquired by Audience. Developer of algorithms and software enabling consumer applications to better understand user contexts and intent.

Cookie Policy Website powered by 100% renewable energy Privacy Policy